- Home
- SMBK vs MGTX Comparison
SMBK vs MGTX Comparison
Compare SMBK & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMBK
- MGTX
- Stock Information
- Founded
- SMBK N/A
- MGTX 2015
- Country
- SMBK United States
- MGTX United States
- Employees
- SMBK N/A
- MGTX N/A
- Industry
- SMBK Major Banks
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMBK Finance
- MGTX Health Care
- Exchange
- SMBK Nasdaq
- MGTX Nasdaq
- Market Cap
- SMBK 494.2M
- MGTX 411.4M
- IPO Year
- SMBK N/A
- MGTX N/A
- Fundamental
- Price
- SMBK $35.63
- MGTX $6.90
- Analyst Decision
- SMBK Buy
- MGTX Strong Buy
- Analyst Count
- SMBK 5
- MGTX 2
- Target Price
- SMBK $28.20
- MGTX $22.50
- AVG Volume (30 Days)
- SMBK 70.2K
- MGTX 457.2K
- Earning Date
- SMBK 10-21-2024
- MGTX 11-12-2024
- Dividend Yield
- SMBK 0.90%
- MGTX N/A
- EPS Growth
- SMBK N/A
- MGTX N/A
- EPS
- SMBK 1.93
- MGTX N/A
- Revenue
- SMBK $159,196,000.00
- MGTX $8,122,000.00
- Revenue This Year
- SMBK N/A
- MGTX N/A
- Revenue Next Year
- SMBK $12.25
- MGTX $5,284.51
- P/E Ratio
- SMBK $18.46
- MGTX N/A
- Revenue Growth
- SMBK 2.18
- MGTX 26.87
- 52 Week Low
- SMBK $19.00
- MGTX $3.85
- 52 Week High
- SMBK $37.72
- MGTX $7.60
- Technical
- Relative Strength Index (RSI)
- SMBK 69.39
- MGTX 78.96
- Support Level
- SMBK $32.25
- MGTX $5.52
- Resistance Level
- SMBK $37.72
- MGTX $6.36
- Average True Range (ATR)
- SMBK 1.02
- MGTX 0.31
- MACD
- SMBK 0.32
- MGTX 0.06
- Stochastic Oscillator
- SMBK 72.40
- MGTX 99.46
About SMBK SmartFinancial Inc.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.